Abbreviations {#nomen0010}
=============

CT

:   Computed Tomography

EBUS

:   endobronchial ultrasound

EUS

:   transesophageal endoscopic ultrasound

EUS-B

:   EUS with EBUS endoscope

FNA

:   fine needle aspiration biopsies

TBNA

:   transbronchial needle aspiration

1. Background {#sec1}
=============

Pulmonologists have traditionally been reluctant to perform transesophageal endoscopic ultrasound (EUS) using the larger gastrointestinal scope \[[@bib1]\], whereas transesophageal endoscopic ultrasound fine needle aspiration biopsies with the smaller EBUS endoscope (EUS-B-FNA) is quickly gaining ground. However, the experiences with the latter are still relatively sparse. EUS-B guided aspiration of ascites fluid has never been described before.

2. Case presentation {#sec2}
====================

A woman aged 71 years was referred to our department because of infiltration in the middle lobe. Five years earlier she had been operated for breast cancer. Computed Tomography (CT) also showed enlarged mediastinal lymph nodes station 4R and 4L (1.5 cm short axis) and small amounts of ascites. Systematic bronchoscopy and endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) were performed and the anlarged lymph nodes were biopsied. Cytopathological evaluation reveiled no malignant cells. In the same session EUS-B was performed. The ascites fluid in the perihepatic region ([Fig. 1](#fig1){ref-type="fig"}) was visualized. A 22G needle was introduced into the ascites, traversing the wall of the stomach ([Fig. 2](#fig2){ref-type="fig"}), and 10 mL was aspirated. Cytopathological evaluation showed mesothelial cells and chronic inflammation. No complications were seen. A few weeks later bone metastases -- probably from the breast cancer - were demonstrated. The patient quickly lost her strenght and died. Autopsy was not performed. In this case, aspiration of ascites by EUS-B-FNA spared the patient for percutaneous ascites aspiration.Fig. 1CT-scan of the patient showing ascites fluid in the perihepatic region.Fig. 1Fig. 2Transesophageal bronchoscopic ultrasound-guided fine needle aspiration of ascites fluid.Fig. 2

3. Discussion {#sec3}
=============

There is increasing evidence for the feasibility and safety of EUS-B-FNA from multiple sites outside the mediastinum such as liver, left adrenal gland or lung \[[@bib2], [@bib3], [@bib4]\]. Our case story demonstrates that EUS-B-FNA from ascites fluid in a patient suspected of lung cancer is possible in the same session as bronchoscopy and EBUS-TBNA. Traditionally diagnostic aspiration of ascites fluid is done percutaneoulsy guided by ultrasound or by the use of EUS \[[@bib5]\]. There are no randomized studies comparing these two techniques. Theoretically, complications to EUS-B-FNA may be bleeding, infection and perforation of the gastrointestinal tract. The EBUS needle is typically 20--40 mm. The risk when using the larger EUS endoscope (EUS needle length 80--90 mm) is extremely low \[[@bib6]\]. In a systematic review of combined EUS-FNA and EBUS-TBNA, severe complications were reported in 0.3% of the patients (one lymph node abscess and one pneumothorax) \[[@bib7]\]. No serious complications to EUS-B-FNA have been reported \[[@bib8]\].

There are obvious logistical and practical advantages in performing EUS-B guided aspiration of ascites in connection with EBUS. We recommend EUS-B guided aspiration of ascites fluid in patients with indication of both diagnostic ascites aspiration and EUS-B for sampling other structures. This may spare the patient from a superfluous percutaneous ascites aspiration.

In conclusion, we hereby demonstrate that EUS-B-FNA from ascites fluid is feasible and appears to be safe.
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